Asset Dedication’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Asset Dedication's ALNY Position: Q3 2026 in Review
Asset Dedication reduced its Alnylam Pharmaceuticals (ALNY) stake by 17% in Q3 2026, selling an estimated $254 and leaving 5 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1057.
Asset Dedication first reported a position in ALNY in Q1 2018 and has held it in 8 quarters since. The position peaked at $9K in Q1 2018. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Asset Dedication held 5 shares of Alnylam Pharmaceuticals worth $1.23K as of Q3 2026.
- Asset Dedication sold 1 Alnylam Pharmaceuticals share in Q3 2026, an estimated $254.
- Alnylam Pharmaceuticals made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1057 holding.
- Asset Dedication first reported a position in Alnylam Pharmaceuticals in Q1 2018 and has held it in 8 quarters since.
- Asset Dedication's Alnylam Pharmaceuticals position peaked at $9K in Q1 2018.
- 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.